Rotator Cuff Tendinopathy Clinical Trial
Official title:
Transcranial Direct Current Stimulation to Enhance Rehabilitation in Individuals With Rotator Cuff Tendinopathy: a Triple-blind Randomized Control Trial
Transcranial direct current stimulation (tDCS), an electrostimulation technique known to modulate the motor cortex excitability, has been shown to enhance the effects of rehabilitation in populations with neurological injuries. tDCS could similarly be effective in individuals with rotator cuff (RC) tendinopathy, as this pathology is also associated with pain and motor control deficits. For the treatment of RC tendinopathy, sensorimotor training is effective to reduce pain, increase function and enhance motor control of the shoulder. The addition of tDCS during sensorimotor training could enhance motor learning associated with sensorimotor training and thus improve treatment outcome. PURPOSE: To compare, in terms of symptoms, functional limitations and shoulder control, a group receiving a rehabilitation program centered on sensorimotor training combined with tDCS to a group receiving the same rehabilitation program combined with sham tDCS in individuals with RC tendinopathy. METHODS: Forty adults with RC tendinopathy will take part in the 4 evaluation sessions (0, 3, 6, 12 weeks) and a 6-week rehabilitation program. Outcome measures will be symptoms and functional limitations (Disability of the Arm, Shoulder and Hand and the Western Ontario Rotator Cuff index), as well as acromiohumeral distance ([AHD] ultrasonographic measurement at 0° and 60° of elevation arm). The rehabilitation program will include sensorimotor training, strengthening and education. tDCS will be apply during sensorimotor training on the motor cortex contralateral to the side of pain. A 2-way ANOVA will be used to analyse the effects of tDCS on the outcomes.
BACKGROUND: tDCS is a safe and easy to use technique that has emerged as a promising tool to
induce plasticity and to facilitate sensorimotor rehabilitation with potential application in
various clinical populations. tDCS has been shown to induce changes that outlast the duration
of the stimulation, by modulating neuronal membrane potential of the targeted brain region.
Depending on the flow of current, tDCS can increase or decrease neuronal excitability; anodal
tDCS induces membrane depolarization and enhanced excitability of cortical neurons, whereas
cathodal tDCS induces membrane hyperpolarization and reduced excitability of cortical
neurons. As such, tDCS has the potential to prime the plastic potential of a given brain
region, making it more responsive to another intervention. For example, it has been shown
that five days of anodal tDCS combined with training promotes motor skill acquisition still
detectable three months later; an effect significantly superior to sham tDCS. These effects
most likely are due to the augmentation of synaptic plasticity that requires the presence of
brain-derived neurotrophic factor.
Coupled with sensorimotor training, tDCS can lead to subsequent sustained clinical gains.The
beneficial effects of tDCS combined with sensorimotor training to normalize motor cortical
activity and to enhance rehabilitation have been shown in populations with neurological
injuries, such a stroke. In musculoskeletal populations, anodal tDCS over M1 has also been
shown to lead to significant pain level reduction. Evidence suggests that tDCS over M1 may
relieve pain through inhibition of thalamic sensory neurons and disinhibition of neurons
located in the periaqueductal gray matter. In these latter studies, tDCS was specifically
aimed at reducing pain and was not coupled with sensorimotor training. In fact, evidence on
the effect of tDCS coupled with sensorimotor training in musculoskeletal populations is
scarce, and the effect of such intervention has never been evaluated in individuals with RC
tendinopathy. Considering that RC tendinopathy is associated with impaired motor control and
that pain can decrease the excitability of the motor cortex and impair motor learning, the
investigators believe that it is relevant to determine whether tDCS can enhance sensorimotor
training, and improve outcome.
PURPOSE - The primary objective of this randomized control trial is to compare, in terms of
symptoms and functional limitations, a group receiving a rehabilitation program centered on
sensorimotor training combined with anodal tDCS to a group receiving the same rehabilitation
program combined with sham tDCS in individuals with RC tendinopathy. A secondary objective is
to explore the effects of these interventions on shoulder control and corticospinal
excitability.
METHODS - Study Design: This triple-blind (patients, therapist & evaluator), parallel-group
randomized control trial will include four evaluation sessions over 6 months (baseline, week
3, week 6, 3-month) and a 6-week rehabilitation program.
Interventions: Each participant will take part in the same 8-week rehabilitation program
supervised by an independent physiotherapist. This program, previously shown effective,
targets the deficits described in individuals with RC tendinopathy. It includes sensorimotor
training, strengthening, and patient education. Each session lasts 40 minutes, with at least
75% for sensorimotor training. The rest of the session is used to teach and revise home
exercises. tDCS will be applied during sensorimotor training (30 min),but only during the
first five sessions, as these sessions will be during the first phase of motor learning,
characterized by considerable improvement in performance.
Statistical Analyses - Descriptive statistics will be used for all outcome measures at each
measurement time to summarise results. Baseline demographic data will be compared
(independent t-test and Chi-squared tests) to establish the comparability of groups. All data
will be tested to check the distributional assumptions for the inferential statistical
analyses. An intention-to-treat analysis will be used in which all participants will be
analysed in the group to which they were originally assigned. All dropouts and the reason for
dropping out of the study will be reported. Any harm or unintended effects during the
programs will be recorded. A 2-way ANOVA (2 tDCS [Real or Sham] x 4 Time [week 0, 3, 6, 12])
will be used to analyse the effects of tDCS on primary outcome and secondary outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05561452 -
The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome
|
N/A | |
Terminated |
NCT03013192 -
Three Month Automated Messaging Intervention
|
N/A | |
Completed |
NCT02881021 -
Effects of Kinesiotaping on Symptoms, Functional Limitations, and Underlying Deficits of Patients With Rotator Cuff Tendinopathy
|
N/A | |
Not yet recruiting |
NCT05969652 -
Comparison of the Effectiveness Heavy Slow Resistance and Eccentric Training in Rotator Cuff Tendinopathy
|
N/A | |
Completed |
NCT05320419 -
The Effect of Amniotic Membrane Injection as An Addition to Physical Therapy in Patients With Rotator Cuff Tear
|
N/A | |
Completed |
NCT03454321 -
IS'ECHO : Impact of Bursitis on the Efficacy of Subacromial Steroid Injection in Rotator Cuff Tendinopathy
|
||
Completed |
NCT06031857 -
Comparison of Kinesio Tape and Dry Needling for the Management of Rotator Cuff Tendinopathy: A Randomized Control Trial
|
N/A | |
Withdrawn |
NCT03032432 -
A Dynamic Elastic Garment (DEG) in Patients With Rotator Cuff Tendinopathy
|
Phase 4 | |
Completed |
NCT05207384 -
Comparison of Subacromial Ozone (O2-O3) and Corticosteroid Injections in the Treatment of Rotator Cuff Tendinopathy
|
N/A | |
Completed |
NCT04766905 -
Mini Lateral Shoulder Approach
|
N/A | |
Active, not recruiting |
NCT05124769 -
PAin During Shoulder Exercise
|
N/A | |
Completed |
NCT01915979 -
Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy
|
Phase 3 | |
Not yet recruiting |
NCT02982460 -
Effects of Isoinertial Training on Rotator Cuff Tendinopathy
|
N/A | |
Active, not recruiting |
NCT05758415 -
Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy
|
Phase 3 | |
Active, not recruiting |
NCT05722522 -
Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy
|
Phase 3 | |
Completed |
NCT01423682 -
The Influence of Eccentric Training on the Volume and Vascularisation of the Rotator Cuff in Patients With Rotator Cuff Tendinopathy and Healthy Subjects
|
N/A |